Current controversies in the surgical management of pancreatic cancer

Ammar Asrar Javed, Kanza Aziz, Christopher Wolfgang

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pancreatic ductal adenocarcinoma is one of the deadliest malignancies with an extremely poor survival rate. Both environmental and hereditary factors play a role in the development of disease, and early diagnosis is difficult due to early systemic involvement of disease. Thus, a majority of patients are not surgical candidates at the time of diagnosis. The treatment of pancreatic cancer is dependent on the stage of disease. Several controversies exist that are relevant to surgery. These include: (1) the use of diagnostic laparoscopy, (2) surgery-first versus neoadjuvant approach, (3) definition of borderline resectable, and (4) ablative therapies for locally unresectable pancreatic cancer. This chapter discusses the current principles of the management related to these topics and their variation across different centers and physicians treating pancreatic cancer.

Original languageEnglish (US)
Title of host publicationCurrent Controversies in Cancer Care for the Surgeon
PublisherSpringer International Publishing
Pages121-132
Number of pages12
ISBN (Print)9783319162058, 9783319162041
DOIs
StatePublished - Jan 1 2015

Fingerprint

Pancreatic Neoplasms
Laparoscopy
Early Diagnosis
Adenocarcinoma
Survival Rate
Physicians
Therapeutics
Neoplasms

Keywords

  • Ablation
  • Borderline resectable
  • Controversies
  • Diagnostic laparoscopy
  • Management
  • Neoadjuvant therapy
  • Pancreatectomy
  • Pancreatic adenocarcinoma
  • Pancreatic cancer
  • Resectability

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Javed, A. A., Aziz, K., & Wolfgang, C. (2015). Current controversies in the surgical management of pancreatic cancer. In Current Controversies in Cancer Care for the Surgeon (pp. 121-132). Springer International Publishing. https://doi.org/10.1007/978-3-319-16205-8_7

Current controversies in the surgical management of pancreatic cancer. / Javed, Ammar Asrar; Aziz, Kanza; Wolfgang, Christopher.

Current Controversies in Cancer Care for the Surgeon. Springer International Publishing, 2015. p. 121-132.

Research output: Chapter in Book/Report/Conference proceedingChapter

Javed, AA, Aziz, K & Wolfgang, C 2015, Current controversies in the surgical management of pancreatic cancer. in Current Controversies in Cancer Care for the Surgeon. Springer International Publishing, pp. 121-132. https://doi.org/10.1007/978-3-319-16205-8_7
Javed AA, Aziz K, Wolfgang C. Current controversies in the surgical management of pancreatic cancer. In Current Controversies in Cancer Care for the Surgeon. Springer International Publishing. 2015. p. 121-132 https://doi.org/10.1007/978-3-319-16205-8_7
Javed, Ammar Asrar ; Aziz, Kanza ; Wolfgang, Christopher. / Current controversies in the surgical management of pancreatic cancer. Current Controversies in Cancer Care for the Surgeon. Springer International Publishing, 2015. pp. 121-132
@inbook{8253a57f53d040f5a009874254951f3d,
title = "Current controversies in the surgical management of pancreatic cancer",
abstract = "Pancreatic ductal adenocarcinoma is one of the deadliest malignancies with an extremely poor survival rate. Both environmental and hereditary factors play a role in the development of disease, and early diagnosis is difficult due to early systemic involvement of disease. Thus, a majority of patients are not surgical candidates at the time of diagnosis. The treatment of pancreatic cancer is dependent on the stage of disease. Several controversies exist that are relevant to surgery. These include: (1) the use of diagnostic laparoscopy, (2) surgery-first versus neoadjuvant approach, (3) definition of borderline resectable, and (4) ablative therapies for locally unresectable pancreatic cancer. This chapter discusses the current principles of the management related to these topics and their variation across different centers and physicians treating pancreatic cancer.",
keywords = "Ablation, Borderline resectable, Controversies, Diagnostic laparoscopy, Management, Neoadjuvant therapy, Pancreatectomy, Pancreatic adenocarcinoma, Pancreatic cancer, Resectability",
author = "Javed, {Ammar Asrar} and Kanza Aziz and Christopher Wolfgang",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-16205-8_7",
language = "English (US)",
isbn = "9783319162058",
pages = "121--132",
booktitle = "Current Controversies in Cancer Care for the Surgeon",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Current controversies in the surgical management of pancreatic cancer

AU - Javed, Ammar Asrar

AU - Aziz, Kanza

AU - Wolfgang, Christopher

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pancreatic ductal adenocarcinoma is one of the deadliest malignancies with an extremely poor survival rate. Both environmental and hereditary factors play a role in the development of disease, and early diagnosis is difficult due to early systemic involvement of disease. Thus, a majority of patients are not surgical candidates at the time of diagnosis. The treatment of pancreatic cancer is dependent on the stage of disease. Several controversies exist that are relevant to surgery. These include: (1) the use of diagnostic laparoscopy, (2) surgery-first versus neoadjuvant approach, (3) definition of borderline resectable, and (4) ablative therapies for locally unresectable pancreatic cancer. This chapter discusses the current principles of the management related to these topics and their variation across different centers and physicians treating pancreatic cancer.

AB - Pancreatic ductal adenocarcinoma is one of the deadliest malignancies with an extremely poor survival rate. Both environmental and hereditary factors play a role in the development of disease, and early diagnosis is difficult due to early systemic involvement of disease. Thus, a majority of patients are not surgical candidates at the time of diagnosis. The treatment of pancreatic cancer is dependent on the stage of disease. Several controversies exist that are relevant to surgery. These include: (1) the use of diagnostic laparoscopy, (2) surgery-first versus neoadjuvant approach, (3) definition of borderline resectable, and (4) ablative therapies for locally unresectable pancreatic cancer. This chapter discusses the current principles of the management related to these topics and their variation across different centers and physicians treating pancreatic cancer.

KW - Ablation

KW - Borderline resectable

KW - Controversies

KW - Diagnostic laparoscopy

KW - Management

KW - Neoadjuvant therapy

KW - Pancreatectomy

KW - Pancreatic adenocarcinoma

KW - Pancreatic cancer

KW - Resectability

UR - http://www.scopus.com/inward/record.url?scp=84958891128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958891128&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-16205-8_7

DO - 10.1007/978-3-319-16205-8_7

M3 - Chapter

AN - SCOPUS:84958891128

SN - 9783319162058

SN - 9783319162041

SP - 121

EP - 132

BT - Current Controversies in Cancer Care for the Surgeon

PB - Springer International Publishing

ER -